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The synthesis of ~-alanyl-L-prolyl-L-prolyl-glycyl-L-phenyl­
-alany 1-y-amino butyry 1-L-proly 1-L-pheny lalany 1-~-alanine (I), as an 
analog of Bradykinin, and ~-alanyl-glycyl-glycyl-~-alanyl-glycyl­
-glycine (II) by the solid phase method were described. 
INTRODUCTION 
The structural alterations of naturally occurring peptides ·by the insertion 
of B- or y-amino acids could clarify the relationship between their primary 
structures and the accessibilities of their active centres. Namely, the homologa-
tion of a peptide chain to a more flexible oligomer by lengthening the 
chain of some amino acid unit could bring the active centre of the adjoining 
a-amino acid outwards from the body of the peptide chain and disclose it for 
biological interactions1 • 
The structure of naturally occurring di- and tri-peptides already containing 
B-alanine and y-aminobutyric acid2- 5 stimulated our search toward homologous 
tri- and hexa-peptides6• This paper deals with the preparation of nonapeptide, 
Bradykinin analog (I), bearing 'B-alanine in position 1 and 9 in place of arginine 
and y-aminobutyric acid in position 6 in place of serine. Thus, the biological 
potency of Bradykinin, first isolated from a plasma globulin7 as hypotensive 
factor 
H-B-Ala-L-Pro-L-Pro-Gly-L-Phe-y-ABut-L-Pro-L-Phe-B-Ala-OH 
1 2 34 5 6 7 8 9 
(I) 
and excitant of smooth ·muscles, could also emerge from this synthesis, espe-
cially in respect to its biologically active centres. 
Many Bradykinin analogs containing a-amino acids were described by 
several authors8- 11 . Bradykinin itself has been synthesized by conventional 
method12- 15 and more efficiently by the solid-phase method developed by 
Merrifield16. In the present work, the adoption of the improved solid-phase 
procedure17•18 was shown to be the most convenient one for the synthesis of 
nonapeptide I. Namely, N-t-butoxycarbonyl derivatives of B-alanine19 and 
y-aminobutyric acid20 in condensation processes behaved similarly as a -amino 
acids. It is worth noting that the solid-phase method made feasible the 
synthesis of hitherto unknown B-alanyl-diglycyl-B-alanyl-glycyl-glycine (II) . 
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In order to synthesize the Bradykinin analog I, N-t-butoxycarbonyl-j3-
-alanine19 was first coupled with chloromethylcopolystyrene-divinylbenzene 
(98 : 2) in ethyl acetate and in the presence of triethylamine. The thus obtained 
N-t-butoxycarbonyl-amino acid ester (III) was N-deprotected in 1 molar hydro-
chloric acid - acetic acid solution generating the corresponding hydro-
(III) R=BOC, n=2 
(IV) R =H · HCl, n=2 
(V) R=H, n=2 
(VI) R=BOC, n=l 
BOC= N-t-butoxycarbonyl 
chloride IV and then the free base V by treatment with triethylamine. 
The coupling of polymer-amino acid ester V with an excess of N-t-butoxycar-
bonyl-L-phenylalanine21 was allowed to proceed for 2 h in dimethylformamide 
in the presence of dicyclohexylcarbodi-imide. 
The lengthening of the peptide chain by one amino acid residue was 
completed in about 4 h using N-t-butoxycarbonyl-amino acid as the units. 
Namely, the milder conditions for each deacylation of the thus protected poly-
merpeptide intermediates are decisive in preserving the initial ester22 bond of 
polymer-amino acid V. Thus, in exactly the same way and in the same vessel 
the peptide chain was smoothly lengthened by the stepwise addition of the 
N-t-butoxycarbonyl derivatives of L-proline20 , y-aminobutyric acid20 , L-phenyl-
alanine21, glycine21, L-proline, L-proline, and B-alanine.19 Finally, N-t-butoxy-
car bony 1-B-alany 1-L-proly 1-L-proly 1-glycy 1-L-pheny lalany 1-y-amino bu tyry l-L-
-proly l-1-pheny lalany l-B-al anine was cleaved from solid support by treatment 
with HBr trifluoroacetic acid. 
The crude product was chromatographed and successfully purified on a 
Dowex 50 X5 column, by a gradient elution at various ionic concentrations 
(pH of buffer solutions) of pyridine in acetic acid (pH = 5.6 - 3.1). The struc-
ture and the purity of the thus obtained product, Rf ca. 0.58, (TLC on cellulose 
and development by amyl alcohol-pyridine-water), was evaluated by mass 
spectroscopy and amino acid and elemental analyses. 
The mass spectrum fragmentation pattern of nonapeptide I indicated »ami-
noacyl type« cleavage23•24 evidenced by the corresponding peaks for fragments 
of Pro-Phe, Pro-Pro, Pro-B-Ala, Pro-Gly, y-ABut, B-Ala, and Gly. In addition 
the fragmentation of L-phenylalanine exhibited the tropilium kation at m/e 91. 
An acid hydrolysate of nonapeptide I was analyzed on a Beckman-Unichrom 
Amino Acid Analyzer. The following molar ratios for amino acids were 
obtained: 3.03 (Pro), 1.03 (Gly), 2.10 ((B-Ala), 2.16 (Phe), and LOO (y-ABut). 
The polymeric ester used in the synthesis of B-alanine-hexapeptide (II) 
was preformed in ethyl acetate by coupling the N-t-butoxycarbonyl-glycine 
with chloromethylcopolystyrene-divinylbenzene (2'0/o) in the presence of triethyl-
amine. The thus obtained ester VI was lengthened by condensations with 
N-t-butoxycarbonyl derivatives of glycine21 and B-alanine19 in the properly 
chosen order using the DCCI method in activation, and 1 molar HCl-HOAc 
in N-deprotections processes. The cleavage of the product II from the supporting 
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polymer was affected by a stream of HBr in trifluoroacetic acid. The liberation 
of the thus obtained hydrobromide through an Amberlite IR-4B (OH) column 
afforded hitherto unknown B-alanyl-glycyl-glycyl-B-alanyl-glycyl-glycine (II) 
in 590/o yield, identified by mass spectrum and elemental analysis. 
EXPERIMENTAL 
The same techniques and apparatus were used as described previously25• In 
addition, the »DC-fertigplatten cellulose F« was used for TLC. The content of amino 
acids was determined by Beckman-Unichrom Amino Acid Analyzer. 
Chloromethylcopolymer 
The cross-linked copolymer of styrene and divinylbenzene at - molar ratio of 
98 : 2 (10 g) (400 mesh beads, Dow Chemical Co.) was suspended in 1 molar NaOH 
(68 ml), stirred for 2 h at room t~mperature and washed with water. The resin was 
then suspended in 1 molar HCl (68 ml), stirred at room temperature for 3 h , washed 
with water and successively with dimethylformamide (3 X 15 ml) and methanol 
(3 x 15 ml). The beads were dried at 80 °c and 10-3 mm Hg* for 48 h and suspended 
in freshly distilled chloromethylmethyl ether20 (50 ml) . To this suspension stirred 
for (a) 60 min or (b) 90 min at room temperature, cooled at - 8 °c, a solution of SnCl4 
(1 ml) in chloromethyl ether (20 ml) was added and stirred at 0 <l'C for an additional 
60 min. The solvent was removed under reduced pressure and the polymeric chloro: 
methylated products under a) and b) successively washed with dioxane - water 
(3 : 1, 200 ml), dioxane - 3 molar HCl (3 : 1, 200 ml), dioxane - wat,er (1 : 1, 200 ml), 
dioxane - ethanol (1 : 1, 200 ml) , and finally with methanol (200 ml), then dried for 
48 h at 80 <l'C and 10-3 mm Hg. 
Anal. found: Cl a) 4.62°/o 
b) 7.260/o 
N-t-Butoxycarbonyl-glycyl-copolymer (VI) 
a) To a suspension of chloromethylated copolymer (3 g; Cl 4.620/o) in ethyl acetate 
(50 ml) N-t-butoxycarbonyl-glycine (685 mg, 3.9 mmol) and triethylamine (0.45 ml, 
3.2 mmol) were added, heated and stirred under reflux for 48 h. The product was 
separated by suction and successively washed with ethyl acetate (200 ml), ethanol 
(200 ml), water (200 ml), and methanol (200 ml), and then dried at room temperature 
and 5 · 10-2 mm Hg for 24 h. 
Anal. found: N 0.270/o (0.193 mmol/g copolymer) 
b) From chloromethylated copolymer (3 g; Cl 7.260/o) the product was obtained 
under the above described conditions. 
Anal. found: N 0.430/o (0.31 mmol/g copolymer) 
N-t-Butoxycarbonyl-B-alanyl-copolymer (IV) 
To a suspension of chloromethylated copolymer (10 g; Cl 6.950/o) in ethyl acetate 
(70 ml) N-t-butoxycarbonyl-~-alanine (3.7 g, 19.6 mmol) and triethylamine (2.5 ml, 
17.8 mmol) were added and worked up as described for ester VI. 
Anal. found: N 1.490/o (1.06 mmol/g copolymer) 
B-Alanyl-glycyl-glycyl-B-alanyl-glycyl-glycine (II) 
N-t-Butoxycarbonyl-glycyl-copolymer (VI) (3 g, 0.93 mmol) was washed with 
acetic acid (20 ml) in a specially constructed vessel18, treated with 1 molar HCl in acetic 
acid (20 ml) by shaking at room temperature for 15 min, filtered through a fritted 
glass disk, successively washed with acetic acid, anhydrous ethanol and dimethyl-
formamide (each 3 X 20 ml) by 5 min shaking period and filtration after each wash. 
* 1 mm Hg = 133.322 Pa 
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The resin - ester was then suspended in dimethylformamide (20 ml) and triethyl-
amine (2.0 ml) by shaking to be separated by suction and washings with dimethyl-
formamide (3 X 20 ml) and methylene chloride (3 X 20 ml). To the thus purified resin-
-ester suspended in dimethylformamide (20 m l), N-t-butoxycarbonyl-glycine (472 mg, 
2.7 mmol) and dicyclohexylcarbodi-imide (558 mg, 2.7 mmol) dissolved in dimethyl-
formamide (2 m l) were added. The suspension was shaken at room temperature for 
2 h, the solvent removed by suction and the product washed with 10 ml portions 
of dimethylformamide and acetic acid (each 3 times). The subsequent deprotections 
and couplings with N-t-butoxycarbonyl derivatives of B-Ala, Gly, Gly, and finally 
B-Ala followed the above described procedure. The final deprotection by 1 molar 
HCl in acetic acid afforded a product which, after having been washed and dried, 
was suspended in trifluoroacetic acid (20 ml). A slow stream of anhydrous hydrogen 
bromide was bubbled through this suspension for 90 min, and then set aside at room 
temperature for 60 min. The resin was filtered off and washed with trifluoroacetic 
acid (3 X 20 ml). The filtrate and washings were evaporated to dryness under reduced 
pressure (at 25 °C), triturated with water, and the filtrate lyophilized. The water 
solution of the thus obtained product (330 mg) was passed through an Amberlite 
IR-4B (OH) (45 ml) column. It afforded a crystalline product (223 mg, 590/o), m . p. 
220-230 °c (from water-ethanol), R1 ca. 0.38 (butanol- acetic acid - water = 1 : 1 : 1). 
Anal. C14H24N607 ·H20 (406.40) calc'd.: C 41.38; H 6.46; N 20.680/o 
found: C 41.19; H 6.23 ; N 20.360/o 
IR spectrum: vmax 3333, 1613 br, and 1563 br cm-1. MS (m/e): 128 (HNCH2CHr 
CONHCH2CO) , 114 (HNCH2CONHCH2CO), 71 (HNCH2CH2CO), 57 (HNCH2CO), 42 
(CH2CO), and 30 (H2NCH2). 
~-Alanyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-y-aminobutyryl-L-prolyl­
-L-phenylalanyl-~ -alanine (I) 
N- t-Butoxycarbonyl-B-alanyl-copolymer (III) (5 g, 5.3 mmol) containing 1.490/o N 
(1.06 mmol/g copolymer), was washed with acetic acid (30 ml) and then treated with 
1 molar HCl in acetic acid (20 ml) as already described. B- Alanyl-resin was washed 
with 30 ml portions of acetic acid, ethanol, and methylene chlorid e (3 times by each) 
by shaking for 5 min followed by filtration. After treatment with triethylamine (2 ml) 
in methylene chloride (20 ml), filtration and washing with methylene chloride (4 x 30 
ml) N-t-butoxycarbonyl-L-phenylalanine (4.22 g, 15.9 mmol) in methylene chloride 
(20 ml) was added and shaken for 10 min. To this suspension N,N-dicyclohexylcarbodi-
-imide (DCCI) (3.28 g, 15.9 mmol) was added and shaken for an additional 2 h to be 
filtered and washed with methylene chloride, ethanol, and acetic acid (each 3 x 30 
ml). The subsequent seven amino acids [-Pro(7), -y- ABut(6), -Phe(5), - Gly(4), -Pro(3), 
-Pro(2), and -B-Ala(l)] as N-t-butoxycarbonyl derivatives were coupled in the presence 
of DCCI (3.28 g, 15.9 mmol) and triethylamine (2 ml) in methylene chloride (20 ml) and 
N-deprotected in 1 molar HCl - acetic acid (20 ml) except after B-alanine (1) had 
been coupled. 
The N-protected nonapeptide-polymer was dried and suspended in anhydrous 
trifluoroacetic acid (30 ml) . The suspension was treated by bubbling anhydrous hydro-
gen bromide at room temperature for 90 min, and then setting it aside for additional 
60 min. The freeze drying of filtrate and trifluoroacetic and acetic acids washings 
afforded the crude product (3.2 g, 59.70/o). 
The solution of crude nonapeptide (I) (200 mg) in 0.2 mmol/dm3 pyridine-acet.ic 
acid (pH 3.1) was purified on a 2.5 X 100 cm Dowex 50 X 5 (pyridinium form) column, 
thermostated at 30 °c. The column was performed by a suspension of resin in 0.2 
molar pyridine- acetic acid buffer (pH 3.1) (1 : 3 v/v), packed under moderate pressure. 
The gradient elution (220 fractions) at a rate of 16/h combining - molar pyridine -
acetic acid (pH 5.6, 2000 ml) and 0.2 molar pyridine-acetic acid (pH 3.1, 2000 ml) 
separated the pure product, R1 ca. 0.58 (cellulose in ethanol-pyridine-water = 
= 1.2 : 1.2 : 1). (The first 824 ml of eluates did not contain the desired product) . The 
sample was dissolved in water, filtered, and freeze dried, m. p . 155-157 °c. 
Anal. C45H54N9010 · 2 CHaCOOH · Hl!O (1011.038) 
calc'd.: C 55.89 ; H 7.08; N 11.980/o 
found : C 55.74; H 7.06; N 12.170/o 
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IR spectrum: Vmax 3333, 3077 br, 2941 br, 1653, and 1534 cm-1. MS (m/e): 245 
(HNPro-PheCO), 195 (HNPro-ProCO), 169 (HNPro-B-AlaCO), 154 (HNPro-GlyCO) , 91 
(tropilium cation), 85 [HN(CH2)aCO], 72 (HNCH2CH2CO), 57 (HNCH2CO). 
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SAZETAK 
Analogon bradikinina sa B-alaninom i y-aminomaslacnom kiselinom 
V. Skaric, M . Topic-BuLic i D. Skaric 
Opisane su sinteze B-alanil-L-prolil-L-prolil-glicil-L-fenilalanil-y-aminobutiril-
-L-prolil-L-fenilalanil-B-alanina i B-alanil-glicil-glicil-B-alanil-glicil-glicina metodom 
krute faze. 
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